Sign in

CIK 0001764013

  • Large accelerated filer

Immunovant, Inc.

Sign in to watch
Ticker
IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
832771572
Phone
+1 917-410-3120
Business address
1000 PARK FORTY PLAZA, DURHAM, NC, 27713
Former names
Health Sciences Acquisitions Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$895,852
in 9 filings, $173K under 10b5-1 plans

Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-04-02 MIGAUSKY GEORGE V Director Grant or award +11,255 121,063
2024-04-02 MIGAUSKY GEORGE V Director Grant or award · Stock Option (right to buy) +4,690 4,690
2024-04-02 Pande Atul Director Grant or award +11,255 94,413
2024-04-02 Pande Atul Director Grant or award · Stock Option (right to buy) +4,690 4,690
2024-04-02 Torti Frank Director Grant or award +120,400 635,674
2024-04-02 Torti Frank Director Grant or award · Stock Option (right to buy) +50,167 50,167
2024-04-02 Stout Jay S Chief Technology Officer Grant or award +54,978 154,978
2024-04-02 Stout Jay S Chief Technology Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Levine Mark S. Chief Legal Officer Grant or award +54,978 356,946
2024-04-02 Levine Mark S. Chief Legal Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Macias William L. Chief Medical Officer Grant or award +54,978 385,930
2024-04-02 Macias William L. Chief Medical Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Geffner Michael Chief Medical Officer Grant or award +54,978 144,877
2024-04-02 Geffner Michael Chief Medical Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Butchko Julia G. Chief Development Officer Grant or award +54,978 462,795
2024-04-02 Butchko Julia G. Chief Development Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Barnett Eva Renee Chief Financial Officer Grant or award +54,978 375,398
2024-04-02 Barnett Eva Renee Chief Financial Officer Grant or award · Stock Option (right to buy) +68,723 68,723
2024-04-02 Salzmann Peter Chief Executive Officer Grant or award +160,534 1,091,765
2024-04-02 Salzmann Peter Chief Executive Officer Grant or award · Stock Option (right to buy) +200,667 200,667

Page 14 of 18 · 351 trades